PT - JOURNAL ARTICLE AU - Luo, Xiaomin AU - Zhou, Wei AU - Yan, Xiaojie AU - Guo, Tangxi AU - Wang, Benchao AU - Xia, Hongxia AU - Ye, Lu AU - Xiong, Jun AU - Jiang, Zongping AU - Liu, Yu AU - Zhang, Bicheng AU - Yang, Weize TI - Prognostic value of C-reactive protein in patients with COVID-19 AID - 10.1101/2020.03.21.20040360 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.21.20040360 4099 - http://medrxiv.org/content/early/2020/03/23/2020.03.21.20040360.short 4100 - http://medrxiv.org/content/early/2020/03/23/2020.03.21.20040360.full AB - Background Elevated serum C-reactive protein (CRP) level was observed in most patients with COVID-19.Methods Data of COVID-19 patients with clinical outcome in a designated hospital in Wuhan, China, were retrospectively collected and analyzed from Jan 30 to Feb 20, 2020. The prognostic value of admission CRP was evaluated in patients with COVID-19.Results Out of 298 patients enrolled, 84 died and 214 recovered. Most non-survivors tended to be males, old aged, or with chronic diseases. Compared to survivors, non-survivors showed significantly elevated white blood cell and neutrophil count, neutrophil to lymphocyte ratio (NLR), systemic immune-inflammation index (SII, defined by platelet count multiply by NLR), CRP, procalcitonin, and D-dimer, and decreased red blood cell, lymphocyte, and platelet count. Age, neutrophil count, platelet count, and CRP were identified as independent predictors of adverse outcome. The area under the receiver operating characteristic (ROC) curve (AUC) of CRP (0.896) was significantly higher than that of age (0.833), neutrophil count (0.820), and platelet count (0.678) in outcome prediction (all p<0.05). With a cut-off value of 41.4, CRP exhibited sensitivity 90.5%, specificity 77.6%, positive predictive value 61.3%, and negative predictive value 95.4%. Subgroup analysis revealed that CRP remained robust accuracy in adverse outcome prediction in patients with different disease severity (AUC 0.832, z=10.23, p<0.001; AUC 0.989, z=44.04, p<0.001). CRP was also an independent discriminator of severe/critical illness on admission (AUC 0.783, z=10.69, p<0.001).Conclusions In patients with COVID-19, admission CRP correlated with disease severity and tended to be a good predictor of adverse outcome.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data sets that support the findings of this study are available from the corresponding author on reasonable request.